Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3...

por Caputo, Roberta, Fabi, Alessandra, Romagnoli, Emanuela, Baldini, Editta, Grasso, Donatella, Fenderico, Nicola, Michelotti, Andrea
Publicado 2022

Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER(+)HER2(−)Rb wild-type and knock-down in breast cancer cell lines

por Marinelli, Oliviero, Romagnoli, Emanuela, Maggi, Federica, Nabissi, Massimo, Amantini, Consuelo, Morelli, Maria Beatrice, Santoni, Matteo, Battelli, Nicola, Santoni, Giorgio
Publicado 2020

Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implicatio...

por Occhipinti, Giulia, Romagnoli, Emanuela, Santoni, Matteo, Cimadamore, Alessia, Sorgentoni, Giulia, Cecati, Monia, Giulietti, Matteo, Battelli, Nicola, Maccioni, Alessandro, Storti, Nadia, Cheng, Liang, Principato, Giovanni, Montironi, Rodolfo, Piva, Francesco
Publicado 2020

Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicent...

por La Verde, Nicla, Damia, Giovanna, Garrone, Ornella, Santini, Daniele, Fabi, Alessandra, Ciccarese, Mariangela, Generali, Daniele Giulio, Nunzi, Martina, Poletto, Elena, Ferraris, Elisa, Cretella, Elisabetta, Scandurra, Giuseppa, Meattini, Icro, Bertolini, Alessandro Stefano, Cavanna, Luigi, Collovà, Elena, Romagnoli, Emanuela, Rulli, Eliana, Legramandi, Lorenzo, Guffanti, Federica, Bramati, Annalisa, Moretti, Anna, Cassano, Alessandra, Vici, Patrizia, Torri, Valter, Farina, Gabriella
Publicado 2022